Abstract
The selective functionalization of sp3 C–H bonds is a versatile tool for the diversification of organic compounds. Combining attractive features of homogeneous and enzymatic catalysts, artificial metalloenzymes offer an ideal means to selectively modify these inert motifs. Herein, we report on a copper(I) heteroscorpionate complex embedded within streptavidin that catalyzes the intramolecular insertion of a carbene into sp3 C–H bonds. Target residues for genetic optimization of the artificial metalloenzyme were identified by quantum mechanics/molecular mechanics simulations. Double-saturation mutagenesis yielded detailed insight on the contribution of individual amino acids on the activity and the selectivity of the artificial metalloenzyme. Mutagenesis at a third position afforded a set of artificial metalloenzymes that catalyze the enantio- and regioselective formation of β- and γ-lactams with high turnovers and promising enantioselectivities.
Introduction
The selective functionalization of inert C–H bonds currently lies at the forefront of modern synthetic chemistry. It alleviates the laborious interconversion of functional groups, minimizes the number of synthetic steps, and enables capitalizing on previously inaccessible bond formation strategies.1−3 This reduces the environmental footprint of lengthy chemical processes.
Thus far, the field of homogeneous C–H functionalization has been mostly dominated by precious-metal catalysts used in combination with directing groups and is often performed at elevated temperatures.4 One of the recurring challenges faced with such methodologies is the reductive elimination of the stable M–C bond.5 An attractive approach to circumvent this limitation is the insertion of a reactive M–X species into the C–H bond of a substrate that does not interact with the metal (Scheme S1).6−9 Largely developed by Pérez and co-workers, complexes bearing a tris(pyrazolyl)borate (Tp) ligand have been shown to enable the functionalization of simple alkanes with carbene, nitrene, and oxo intermediates.9−11 The pyrazole motif offers the possibility to readily fine-tune both steric and electronic properties of the TpM-catalyst to achieve the desired reactivity. Remarkably, perfluorinated azolylborate complexes of silver and copper catalyze the functionalization of methane in supercritical CO2 with ethyl diazoacetate.12,13 However, this system occasionally yielded complex mixtures of regioisomers when substrates containing different C–H bonds were subjected to functionalization.
With the aim of combining the benefits of homogeneous and enzymatic catalysts, artificial metalloenzymes (ArMs) have attracted increasing attention since the pioneering work of Wilson and Whitesides.14−17 The anchoring of an abiotic catalytic moiety within a protein enables combining of attractive assets of both homogeneous and enzymatic catalysis.17−21 Certain natural enzymes including S-adenosyl methionine-dependent (SAM) enzymes catalyze the alkylation of C–H bonds. They are however mainly limited to the transfer of methyl groups or highly specific C–C bonds with radical acceptors.22,23 Repurposed (natural) enzymes and ArMs offer an attractive means to complement SAM-dependent enzymes for C–H activation purposes.21,24−28 Among the most noteworthy achievements in “new-to-nature” C–C bond formation via C–H functionalization, one should mention engineered P411,29,30 repurposed P450,31−34 myoglobin,35,36 and streptavidin37,38 ArMs. However, examples of highly active C–H insertion biocatalysts that are based on first-row transition metals and tolerate aerobic reaction conditions remain scarce. The work presented herein capitalizes on a Cu(I) heteroscorpionate complex to engineer a highly active ArM that catalyzes the intramolecular insertion of carbenes into different types of C–H bonds in a regio- and enantioselective fashion.
Results and Discussion
Cofactor Synthesis and Computational Modeling
The remarkable affinity of biotin for streptavidin (Kd < 10–13 M) offers an attractive means to anchor any biotinylated probe within streptavidin (Sav). Several groups have relied on this tool to assemble ArMs.14,37−46 A common strategy for the synthesis of anchored Tp complexes relies on the introduction of a fourth substituent on the boron, replacing the hydride moiety.47−49 In our hands, however, this strategy proved challenging as tetrasubstituted Tp-derivatives bearing electron-deficient pyrazoles revealed insufficient stability. Inspired by the work of Desrochers and co-workers on heterocycle metathesis,50 we selected the Tp(tBu)2K 1 as the precursor for the assembly of a biotinylated, electron-deficient TpM-cofactor. The pronounced steric bulk around the boron enabled the selective substitution of the three tert-butyl pyrazole groups by the benzotriazole 2 bearing an activated ester and two tribromopyrazole moieties to afford the intermediate 3, albeit in low yield, as shown in Scheme 1a. This intermediate was characterized by X-ray crystallography (Figure S1). Trans-metalation with cuprous chloride yielded compound 4, which was also characterized by X-ray crystallography (Figure S2). Interestingly, the structure revealed that the benzotriazole coordinates to a second copper center through the third nitrogen to afford a dimeric structure. To ensure additional electron-deficient character to the cofactor, the benzotriazole was equipped with a carboxylate moiety. Coupling to biotin thus required the use of biotin–amine (i.e., biotC4–NH2),51 rather than biotin, which bears a valeric acid. The biotinylated cofactor biotC4–TazCu was assembled by reacting biotC4–NH2 with the activated ester 4 to ensure its localization within Sav, as shown in Scheme 1b. High-resolution mass spectrometry (HRMS) and detailed nuclear magnetic resonance (NMR) analysis enabled unambiguous characterization of the biotinylated cofactor biotC4–TazCu (see Supporting Information Figures S3–S5).
Scheme 1. Artificial Metalloenzyme for C–H Insertion Resulting from Anchoring a Biotinylated Copper(I) Heteroscorpionate Complex in Sav (Streptavidin).
(a) Synthesis of the cofactor via pyrazole/triazole metathesis on Tp(tBu)2K 1 and conjugation with a modified biotin anchor to afford the cofactor biotC4–TazCu. PFP = pentafluorophenyl; (b) artificial metalloenzyme assembly via supramolecular anchoring of biotC4–TazCu into Sav. The assembled artificial metalloenzyme catalyzes the formation of β- and γ-lactams via intramolecular C–H insertion of carbene intermediates.
The quantitative anchoring of the cofactor biotC4–TazCu into Sav was assessed via CD spectroscopy, as shown in Figure S6.52 The overall binding affinity relies on a one-to-one binding stoichiometry with the mathematical expression derived in the Supporting Information (Figure S6).53 The fitted dissociation constant was Kd = 2.37 ± 1.40·10–8 M, thus leading to >99% of bound biotC4–TazCu in the presence of equimolar concentrations of the cofactor and tetrameric Sav. Unfortunately, all attempts to crystallize the ArM: biotC4–TazCu·Sav WT were vain. Accordingly, we turned to quantum mechanics/molecular mechanics (QM/MM) calculations to model biotC4–TazCu·Sav WT ArM (see the Supporting Information for details). Both the HABA displacement titration and the QM/MM modeling confirmed that up to four biotC4–TazCu cofactors could be accommodated in the homotetrameric host Sav WT. Amino acids that point toward the docked Cu-center include K121, S112, and L124 with a second, more remote shell that includes T114, T115, and N118, Figure 1. Based on the computed structure, we selected residues K121, S112, and L124 for the genetic optimization of the ArM.
Figure 1.

Close-up view of the structure resulting from modeling biotC4–TazCu within Sav WT. The cofactor was docked into one monomer (Sav′, gray), leaving the adjacent (Sav″, pale blue) binding site empty. Cu–Cβ distances (Å) of the closest-lying amino acid: S112′ (11.8); T114′ (11.9); T115′ (14.3); N118′ (10.1); K121′ (8.1); L124′ (13.8); S112″ (10.5); T114″ (12.3); T115″ (15.6); N118″ (12.2); K121″ (9.9); L124″ (12.9). Sav is displayed as a transparent solvent-accessible surface overlaid with a cartoon representation of the 8-stranded β-barrel. Close-lying residues and the biotC4–TazCu cofactor are displayed as color-coded sticks and Cu as an orange sphere.
Single-Mutant Screening
Reports by Pérez and co-workers suggest that sterically hindered diazoacetamides are less prone to undergo homocoupling in copper tris(pyrazolyl)borate-catalyzed intramolecular C–H insertion reactions.54 The diazoacetamide substrate 5 was selected for initial screening, as shown in Table 1. This reaction is of particular interest as it provides a straightforward access to β- and γ-lactams upon C–H insertion. These represent ubiquitous structural motifs in numerous pharmaceutically relevant compounds.55−57 Similarly, Fasan and co-workers reported the stereoselective formation of fused γ-lactams via biocatalytic intramolecular cyclopropanation of diazoacetamide.58
Table 1. Summary of the Screening Results of biotC4–TazCu·Sav K121X for the C–H Insertion in the Presence of Substrate 5.
| entry | SAV | TONa | e.r.a | TONa | e.r.a | r.r. (β/γ) | TTON (yield (%)) |
|---|---|---|---|---|---|---|---|
| 1b,c | ND | ND | ND | ||||
| 2c | empty vector | 91 | 50:50 | 280 | 50:50 | 24:76 | 371(7,4) |
| 3 | empty vector | 112 | 50:50 | 346 | 49:51 | 24:76 | 458(9,2) |
| 4 | K121A | 334 | 49:51 | 577 | 48:52 | 37:63 | 912(18,2) |
| 5 | K121I | 741 | 40:60 | 1708 | 49:51 | 30:70 | 2449(49,0) |
| 6 | K121L | 594 | 36:64 | 1693 | 34:66 | 26:74 | 2287(45,7) |
| 7 | K121M | 109 | 52:48 | 317 | 45:55 | 26:74 | 426(8,5) |
| 8 | K121V | 550 | 41:59 | 1124 | 50:50 | 33:67 | 1674(33,5) |
| 9 | K121F | 709 | 37:63 | 1449 | 64:36 | 33:67 | 2157(43,1) |
| 10 | K121W | 588 | 38:62 | 870 | 49:51 | 40:60 | 1458(29,2) |
| 11 | K121Y | 718 | 39:61 | 923 | 46:54 | 44:56 | 1640(32,8) |
| 12 | K121C | 511 | 44:56 | 768 | 50:50 | 40:60 | 1280(25,6) |
| 13 | K121N | 312 | 43:57 | 358 | 45:55 | 47:53 | 670(13,4) |
| 14 | K121Q | 390 | 40:60 | 506 | 48:52 | 44:56 | 895(17,9) |
| 15 | K121S | 549 | 42:58 | 645 | 51:49 | 46:54 | 1192(23,8) |
| 16 | K121T | 329 | 41:59 | 650 | 45:55 | 34:66 | 979(19,6) |
| 17 | K121D | 62 | 48:52 | 146 | 52:48 | 30:70 | 208(4,2) |
| 18 | K121E | 421 | 40:60 | 560 | 52:48 | 43:57 | 980(19,6) |
| 19 | K121H | ND | ND | ND | |||
| 20 | WT | ND | ND | ND | |||
| 21 | K121R | ND | ND | ND | |||
| 22 | K121G | 455 | 51:49 | 753 | 49:51 | 38:62 | 1208(24,2) |
| 23 | K121P | 365 | 50:50 | 626 | 55:45 | 37:63 | 991(19,8) |
Determined by chiral SFC using 1,3,5-trimethoxybenzene as the internal standard.
The reaction was performed in DCM with 5% DMSO and 5% acetone.
The reaction was performed with complex 4 instead of biotC4–TazCu. ND = not detected.
As the cofactor’s activity was affected by the presence of cellular metabolites, we adapted a purification protocol of Sav mutants in a 96-well plate based on our streamlined protocol.59 Cytoplasmic protein overexpression was carried out in the E. coli strain BL21 (DE3) in 24-deep-well plates. Following cell lysis and centrifugation, the cell-free extract was applied to an iminobiotin-Sepharose resin under basic conditions (pH = 10.6, 100 mM carbonate buffer), leading to the immobilization of Sav on the resin. After washing (pH = 7.9, 100 mM MOPS buffer), elution with an acidic solution (pH = 5.5, 100 mM MES buffer) led to protonation of the iminobiotin, thus releasing Sav. Its concentration in the elution buffer was determined via a fluorescence assay with biotin-4-fluorescein, as shown in Figure S7. Concentrations >5 μM Sav (tetramer, >20 μM biotin-binding sites) were obtained for most of the Sav mutants. Early catalytic experiments revealed a decrease in performance with decreasing Sav: biotC4–TazCu ratios (i.e. 1,:1 vs 1:4). We surmise that binding of two biotC4–TazCu in adjacent biotin-binding sites impedes catalytic activity. Accordingly, an excess of biotin-binding sites in the reaction was enforced (e.g., >4 equiv of Sav monomers vs 1 equiv of the cofactor).
To evaluate the effect of residual cellular debris, a culture of E. coli harboring an empty plasmid (i.e., no Sav overexpressed) was subjected to the above iminobiotin purification protocol. The collected eluate was evaluated in catalysis at pH 6.5 in the presence of 1 μM of either complex 4 or biotC4–TazCu (0.02% loading) and the diazoacetamide substrate 5, as shown in Table 1, entries 2 and 3. A 1:3 mixture of racemic β/γ lactams 6a and 6b was obtained with a total turnover number (TTON) of 371 and 458, respectively. To our disappointment, upon incorporation in WT Sav, no conversion could be detected by supercritical fluid chromatography (SFC); see Table 1 (entry 20). As both lysine residues K121 and K121′ were computed to lie closest to Cu, we initiated our genetic optimization efforts by mutating this position. Gratifyingly, the ArM biotC4–TazCu·Sav K121A proved catalytically active and afforded >900 TTONs with a 1:2 r.r. (β/γ, i.e., 6a:6b) but as a (near) racemate; see entry 4. Next, we screened the ArMs resulting from saturation mutagenesis at position Sav K121X; see Table 1. As can be appreciated, the nature of the residue at Sav K121X significantly affects the catalytic performance. From these results, the following trends emerge: positively charged residues at position K121 (Lys, His, and Arg) consistently shut down activity (entries 19, 20, and 21). We hypothesize that such close-lying, potentially coordinating Lewis basic residues may coordinate with the Cu(I), and prevent the formation of the Cu–carbene moiety. On the other hand, apolar (Ile, Leu, and Val) and aromatic residues (Phe, Trp, and Tyr) have a beneficial effect on activity (entries 5, 6, 8, 9, 10, and 11). The ArM biotC4–TazCu·Sav K121L provided 74% γ-lactam with the highest enantiomeric ratios (36:64 and 34:66 for 6a and 6b, respectively) of the single mutants (entry 6). ArM biotC4–TazCu·Sav K121I displayed the highest activity with 2648 TTON, corresponding to 53% yield (i.e., assay yield, used throughout unless specified). Polar uncharged residues (Asp, Glu, Asn, Gln, Ser, and Thr) generally yielded lower conversions than their apolar counterparts. Interestingly, the mutant bearing an aspartate (entry 17) impeded the reaction much more than its glutamate homologue (entry 18). Similar effects on the turnover number (TON) and e.r. could also be observed between the two isosteric residues cysteine and serine (entries 12 and 15). Overall, a large hydrophobic residue at Sav K121I/L/F appeared essential to maximize the three figures of merit TTON, r.r., and e.r. Interestingly, the ArM also afforded non-negligible amounts of the Büchner ring-expansion product depending on the mutant tested (see the Supporting Information for details). Water insertion and diazo-coupling byproducts could be detected by ESI–MS of the catalytic reactions but were not investigated further (Scheme S2). Although reported for C–H bonds of methyl groups in Rh- and TpCu-based catalysts,54,60 C–H insertion into the tert-butyl group was not detected, thus minimizing the formation of additional regioisomers.
Double-Saturation Mutagenesis
With the aim of identifying synergistic interactions between residues K121 and S112, we set out to screen the double-saturation mutagenesis library comprising the 400 Sav isoforms Sav S112X K121X′. Of the 400 double mutants, 362 could be screened and 220 afforded detectable levels of activity (see Table S1). The general trends observed in the single-mutant Sav K121X screening were confirmed for the double mutants. Positively charged residues (His, Lys, and Arg) consistently impeded activity, particularly at position K121, where none of the three were tolerated, irrespective of the nature of residue S112X, as shown in Figure 2a. Proline and cysteine displayed a deleterious influence as well at both S112 and K121 positions. The unexpected difference between the homologous amino acids aspartate and glutamate was also visible in this screening. The aspartate residue proved to be less advantageous than glutamate at both positions. An apolar side chain (aliphatic or aromatic) at position K121 turned out to be an absolute requirement to obtain a higher activity of the ArM. While the two isoforms leucine and isoleucine provided comparable levels of activity at positions K121 and S112, a pronounced difference in enantioselectivity was observed, as shown in Figure 2b,c. The leucine residue afforded much higher levels of enantio-induction for both the β-lactam 6a and the γ-lactam 6b on average. The asparagine at position S112 appeared to be crucial for enantioselectivity for both reaction products. Among other occurrences, K121V, K121E, and K121Q had a positive influence on the enantioselective formation of 6a but turned out to be less relevant for the other regioisomer 6b.
Figure 2.
Relative contribution of each amino acid at positions S112 and K121 to (a) TON for C–H insertion (average of all the double mutants for a respective mutation); (b) and (c) enantio-induction for the β-lactam 6a and the γ-lactam 6b, respectively (average of the absolute enantiomeric excess value for all the double mutants with a respective mutation). Amino acids with similar properties are highlighted in the same color (light blue: apolar; green: aromatic; yellow: polar nonionic; dark blue: basic; red: acidic; purple: special). The enantioselectivity obtained with residues H, K, and R is not displayed due to the very low conversions.
To help identify a suitable double mutant subject to another round of directed evolution, we analyzed e.r, r.r., and TTON by displaying the e.r. versus r.r. for the γ-lactam (+)-6b, as shown in Figure 3. The absolute configuration of the γ-lactam (+)-6b was determined as (S)-6b by comparison with the secondary amide (deprotected, following treatment of (+)-6b with TFA).61 The data reveal a clear trend for the functionalization of the benzylic position. Both enantiomers of the γ-lactam 6b could be accessed, albeit with a higher enantioselectivity for the (S)-6b. Interestingly, mutation of the K121L to K121F while conserving the S112M residue allowed us to invert the enantioselectivity from 28:72 to 91:9 e.r. Variants S112N–K121L and S112N–K121I revealed similar performance. Strikingly, substitution of S112N for S112Q led to an inversion of enantioselectivity (e.g., S112N K121L/I and S112Q K121L/I afford (S)-6b and (R)-6b, respectively). Of note, a pronounced difference in regioselectivity was observed between S112Q-K121L and S112Q-K121I, the former clearly favoring the formation of the γ-lactam 6b, as shown in Figure 3.
Figure 3.
Graphical summary of the screening results of biotC4–TazCu·Sav S112X K121X′ for the C–H insertion of substrate 5 to afford lactams 6a and 6b. The axes display the enantiomeric and the regiomeric ratios of the γ-lactam (S)-6b. Key mutations leading to high e.r. and r.r. include asparagine and methionine at position S112 and a hydrophobic residue at K121.
High levels of activity, regioselectivity, and enantioselectivity could be obtained with the S112N–K121V variant (86:14 e.r., 80% regioselectivity and 2731 TTON). On average, the valine residue did not display as high levels of enantioselectivity as leucine or phenylalanine for 6b, as shown in Figure 2c. This finding highlights the importance of cooperative effects between sites and would not have been identified with an iterative single-site-saturation strategy.
The β-lactam 6a product could not be obtained in >51% r.r. and modest conversion (<10%, < 500 TON). The higher bond dissociation energy of the amide’s vicinal C–H bond (BDE ≈ 93 kcal/mol vs 87 kcal/mol for the benzylic C–H bond, predicted with ALFABET from the corresponding acetamide)62 and the ring strain in the transition state leading the four-membered β-lactam 6a both favor the formation of the γ-lactam 6b. In some occurrences, considerable amounts of the Büchner ring-expansion product were detected. This was particularly pronounced when position S112 contained an aromatic residue (i.e., S112Y or S112F: up to 1783 TON for S112F–K121I; see Figure S8 and Table S2). The second coordination sphere of Sav could also induce enantioselectivity for this transformation (up to 24:76 e.r. for S112F–K121I). Detailed data for selected mutants are collected in Table S3.
L124 Saturation Mutagenesis and Substrate Scope
Critical inspection of the results of the double-saturation mutagenesis screening led us to select the double mutant Sav S112N–K121V for the next round of directed evolution, focusing on residue Sav L124. A library encoding all 20 amino acids was prepared, relying on NDT, VMA, ATG, and TGG codons. The screening revealed that the size of the amino acid at position L124 had a significant impact on both the e.r and r.r. The triple mutant Sav S112N–K121V–L124I led to slightly improved e.r. (88:12) and r.r (14:86) for the γ-lactam (S)-6b, as shown in Figure 4. Strikingly, substitution of the bulky hydrophobic L121I residue by a glycine, Sav S112N–K121V–L124G, led to the preferential formation of the β-lactam 6a with 65:35 r.r. (compared to 19:81 for the parent double mutant) at the cost of a lower TTON. Interestingly, the enantioselectivity was reversed, favoring the β-lactam (−)-6a (identified as the (R)-enantiomer by vibrational circular dichroism spectrometry; see the Supporting Information for details). Attempts to further improve the catalytic performance by applying site-saturation mutagenesis at positions T114, T115, and N118 did not lead to any improvement for either TTON, r.r., or e.r.
Figure 4.
Evolutionary lineage of the ArM for regio- and enantioselective C–H insertion. Initial double-saturation mutagenesis on WT Sav to identify improved double mutants was followed by single-site-saturation mutagenesis at position L124. Mutation of L124 with an isoleucine slightly increased the selectivity of the ArM for the γ-lactam (S)-6b, while a glycine residue favors the β-lactam (−)-6a. The data are the average of biological triplicates.
To further investigate the performance of the earth-abundant ArM, we selected substrates with either a shorter or longer aliphatic chain, as shown in Table 2. Substrate 7 yielded the corresponding β-lactam (+)-8a (corresponding to (R)-8a)63 in 1290 TON and e.r. of 79:21 with biotC4–TazCu·Sav S112N–K121L. To verify if the selective formation of the γ-lactam 6b was caused by the lower BDE of the benzylic C–H bond (BDE ≈ 87 kcal/mol, predicted with ALFABET from the corresponding acetamide),62 we also subjected substrate 9 bearing a propylene spacer (BDE ≈96 kcal/mol for the homobenzylic C–H bond) to the transformation. To our delight, the γ-lactam 10b was obtained with 3585 TON, 88% regioselectivity, and 27:73 e.r with biotC4–TazCu·Sav S112N–K121V. However, regioselectivity could not be tuned to favor the β-lactam 10a when biotC4–TazCu·Sav S112N–K121V–L124G was used: only a modest increase from 12 to 28% β-lactam 10a was observed. The ArM also catalyzed the carbene insertion into a tertiary C–H bond (BDE ≈ 93 kcal/mol)62 with high efficiency: biotC4–TazCu·Sav S112N–K121L afforded the spirocyclic γ-lactam 12b in 93% yield and 4627 TON. The four-membered ring regioisomer could not be detected either by 1H NMR or HPLC. A selection of para-substituted derivatives of substrate 5 was also tested. Significantly lower TON and selectivities were observed, independently of the nature of the substituent. This highlights a preference of the ArM for unsubstituted phenyl rings. Detailed data are collected in Table S4.
Table 2. Selected Results for the Intramolecular C–H Insertion Catalyzed by biotC4–TazCu·Sav mutantsa.
Conditions: 5 mM substrate, 1 μM biotC4–TazCu, >1 μM Savtet, 35 mM MES pH 5.5, 10% acetone, 5% DMSO, 15 h at 25 °C under air.
Yields were determined by SFC with 1,3,5-trimethoxybenzene as the internal standard.
This reaction was also performed on a preparative scale; see Table S1 and Figures S9 and S10.
Yield determined by 1H NMR with 1,3,5-trimethoxybenzene as the internal standard.
Conclusions
While Tp complexes can efficiently functionalize inert sp3 C–H bonds by insertion of a reactive carbene intermediate, the absence of interactions between the metal and the substrate render the selectivity of the reaction challenging to control. This study reveals that this challenge can be addressed by providing a well-structured second coordination sphere around the transition state. The synthesis of a modified biotin-bearing copper(I) heteroscorpionate enabled its incorporation into a genetically evolvable host protein. The resulting ArM catalyzes the enantio- and regioselective formation of β- and γ-lactams via the insertion of a carbene intermediate into secondary and tertiary sp3 C–H bonds. Double-saturation mutagenesis and directed evolution at a third position shed light on individual amino acid contributions to the cofactor’s activity. TONs up to 4627 (corresponding to 93% yield) in the case of the C–H insertion into a cyclohexyl substituent were achieved. We envision that the use of the highly versatile scorpionate complexes for ArMs could open new opportunities to expand the enzymatic repertoire of C–H functionalization strategies, based on earth-abundant metal cofactors.
Acknowledgments
This publication was created as part of NCCR Catalysis (grant number 180544), a National Centre of Competence in Research funded by the Swiss National Science Foundation. T.R.W. further acknowledges funding from an advanced ERC grant (DreAM: the Directed Evolution of Artificial Metalloenzymes, grant agreement 694424). C.R. thanks the analytical team of the Department of Chemistry, Tobias Vornholt for the plasmids, Annika Matt for the help with the NMR spectra, Nico Valerio Igareta for the protein HRMS, and Xiaochun Li-Blatter for the fitting of the CD titration.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.2c03311.
General information, experimental section, schemes, figures, tables, and X-ray reports (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- Bergman R. G. C–H Activation. Nature 2007, 446, 391–393. 10.1038/446391a. [DOI] [PubMed] [Google Scholar]
- Dalton T.; Faber T.; Glorius F. C–H Activation: Toward Sustainability and Applications. ACS Cent. Sci. 2021, 7, 245–261. 10.1021/acscentsci.0c01413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartwig J. F.; Larsen M. A. Undirected, Homogeneous C–H Bond Functionalization: Challenges and Opportunities. ACS Cent. Sci. 2016, 2, 281–292. 10.1021/acscentsci.6b00032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sambiagio C.; Schönbauer D.; Blieck R.; Dao-Huy T.; Pototschnig G.; Schaaf P.; Wiesinger T.; Zia M. F.; Wencel-Delord J.; Besset T.; Maes B. U. W.; Schnürch M. A Comprehensive Overview of Directing Groups Applied in Metal-Catalysed C–H Functionalisation Chemistry. Chem. Soc. Rev. 2018, 47, 6603–6743. 10.1039/C8CS00201K. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Straub B. F. Organotransition Metal Chemistry. From Bonding to Catalysis. Angew. Chem., Int. Ed. 2010, 49, 7622. 10.1002/anie.201004890. [DOI] [Google Scholar]
- Zheng C.; You S.-L. Recent Development of Direct Asymmetric Functionalization of Inert C–H Bonds. RSC Adv. 2014, 4, 6173–6214. 10.1039/C3RA46996D. [DOI] [Google Scholar]
- Gillingham D.; Fei N. Catalytic X–H Insertion Reactions Based on Carbenoids. Chem. Soc. Rev. 2013, 42, 4918–4931. 10.1039/C3CS35496B. [DOI] [PubMed] [Google Scholar]
- Davies H. M. L.; Beckwith R. E. J. Catalytic Enantioselective C–H Activation by Means of Metal–Carbenoid-Induced C–H Insertion. Chem. Rev. 2003, 103, 2861–2904. 10.1021/cr0200217. [DOI] [PubMed] [Google Scholar]
- Muñoz-Molina J. M.; Belderrain T. R.; Pérez P. J. Trispyrazolylborate Coinage Metals Complexes: Structural Features and Catalytic Transformations. Coord. Chem. Rev. 2019, 390, 171–189. 10.1016/j.ccr.2019.03.013. [DOI] [Google Scholar]
- Díaz-Requejo M. M.; Pérez P. J. Copper, Silver and Gold-Based Catalysts for Carbene Addition or Insertion Reactions. J. Organomet. Chem. 2005, 690, 5441–5450. 10.1016/j.jorganchem.2005.07.092. [DOI] [Google Scholar]
- Díaz-Requejo M. M.; Pérez P. J. The TpxM Core in Csp3–H Bond Functionalization Reactions: Comparing Carbene, Nitrene, and Oxo Insertion Processes (Tpx = Scorpionate Ligand; M = Cu, Ag). Eur. J. Inorg. Chem. 2020, 2020, 879–885. 10.1002/ejic.201901168. [DOI] [Google Scholar]
- Caballero A.; Despagnet-Ayoub E.; Mar Díaz-Requejo M.; Díaz-Rodríguez A.; González-Núñez M. E.; Mello R.; Muñoz B. K.; Ojo W.-S.; Asensio G.; Etienne M.; Pérez P. J. Silver-Catalyzed C-C Bond Formation Between Methane and Ethyl Diazoacetate in Supercritical CO2. Science 2011, 332, 835–838. 10.1126/science.1204131. [DOI] [PubMed] [Google Scholar]
- Gava R.; Olmos A.; Noverges B.; Varea T.; Álvarez E.; Belderrain T. R.; Caballero A.; Asensio G.; Pérez P. J. Discovering Copper for Methane C–H Bond Functionalization. ACS Catal. 2015, 5, 3726–3730. 10.1021/acscatal.5b00718. [DOI] [Google Scholar]
- Wilson M. E.; Whitesides G. M. Conversion of a Protein to a Homogeneous Asymmetric Hydrogenation Catalyst by Site-Specific Modification with a Diphosphinerhodium(I) Moiety. J. Am. Chem. Soc. 1978, 100, 306–307. 10.1021/ja00469a064. [DOI] [Google Scholar]
- Reetz M. T. Biocatalysis in Organic Chemistry and Biotechnology: Past, Present, and Future. J. Am. Chem. Soc. 2013, 135, 12480–12496. 10.1021/ja405051f. [DOI] [PubMed] [Google Scholar]
- Schwizer F.; Okamoto Y.; Heinisch T.; Gu Y.; Pellizzoni M. M.; Lebrun V.; Reuter R.; Köhler V.; Lewis J. C.; Ward T. R. Artificial Metalloenzymes: Reaction Scope and Optimization Strategies. Chem. Rev. 2018, 118, 142–231. 10.1021/acs.chemrev.7b00014. [DOI] [PubMed] [Google Scholar]
- Chen K.; Arnold F. H. Engineering New Catalytic Activities in Enzymes. Nat. Catal. 2020, 3, 203–213. 10.1038/s41929-019-0385-5. [DOI] [Google Scholar]
- Hönig M.; Sondermann P.; Turner N. J.; Carreira E. M. Enantioselective Chemo- and Biocatalysis: Partners in Retrosynthesis. Angew. Chem., Int. Ed. 2017, 56, 8942–8973. 10.1002/anie.201612462. [DOI] [PubMed] [Google Scholar]
- Jeschek M.; Panke S.; Ward T. R. Artificial Metalloenzymes on the Verge of New-to-Nature Metabolism. Trends Biotechnol. 2018, 36, 60–72. 10.1016/j.tibtech.2017.10.003. [DOI] [PubMed] [Google Scholar]
- de Souza R. O. M. A.; Miranda L. S. M.; Bornscheuer U. T. A Retrosynthesis Approach for Biocatalysis in Organic Synthesis. Chem.–Eur. J. 2017, 23, 12040–12063. 10.1002/chem.201702235. [DOI] [PubMed] [Google Scholar]
- Perez-Rizquez C.; Rodriguez-Otero A.; Palomo J. M. Combining Enzymes and Organometallic Complexes: Novel Artificial Metalloenzymes and Hybrid Systems for C–H Activation Chemistry. Org. Biomol. Chem. 2019, 17, 7114–7123. 10.1039/C9OB01091B. [DOI] [PubMed] [Google Scholar]
- Bennett M. R.; Shepherd S. A.; Cronin V. A.; Micklefield J. Recent Advances in Methyltransferase Biocatalysis. Curr. Opin. Chem. Biol. 2017, 37, 97–106. 10.1016/j.cbpa.2017.01.020. [DOI] [PubMed] [Google Scholar]
- Yokoyama K.; Lilla E. A. C–C Bond Forming Radical SAM Enzymes Involved in the Construction of Carbon Skeletons of Cofactors and Natural Products. Nat. Prod. Rep. 2018, 35, 660–694. 10.1039/C8NP00006A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis J. C.; Coelho P. S.; Arnold F. H. Enzymatic Functionalization of Carbon–Hydrogen Bonds. Chem. Soc. Rev. 2011, 40, 2003–2021. 10.1039/C0CS00067A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Upp D. M.; Lewis J. C. Selective C–H Bond Functionalization Using Repurposed or Artificial Metalloenzymes. Curr. Opin. Chem. Biol. 2017, 37, 48–55. 10.1016/j.cbpa.2016.12.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang R. K.; Huang X.; Arnold F. H. Selective CH Bond Functionalization with Engineered Heme Proteins: New Tools to Generate Complexity. Curr. Opin. Chem. Biol. 2019, 49, 67–75. 10.1016/j.cbpa.2018.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zetzsche L. E.; Narayan A. R. H. Broadening the Scope of Biocatalytic C–C Bond Formation. Nat. Rev. Chem. 2020, 4, 334–346. 10.1038/s41570-020-0191-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ren X.; Fasan R. Engineered and Artificial Metalloenzymes for Selective C–H Functionalization. Curr. Opin. Green Sustainable Chem. 2021, 31, 100494. 10.1016/j.cogsc.2021.100494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang R. K.; Chen K.; Huang X.; Wohlschlager L.; Renata H.; Arnold F. H. Enzymatic Assembly of Carbon–Carbon Bonds via Iron-Catalysed Sp3 C–H Functionalization. Nature 2019, 565, 67–72. 10.1038/s41586-018-0808-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang J.; Huang X.; Zhang R. K.; Arnold F. H. Enantiodivergent α-Amino C–H Fluoroalkylation Catalyzed by Engineered Cytochrome P450s. J. Am. Chem. Soc. 2019, 141, 9798–9802. 10.1021/jacs.9b04344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dydio P.; Key H. M.; Nazarenko A.; Rha J. Y.-E.; Seyedkazemi V.; Clark D. S.; Hartwig J. F. An Artificial Metalloenzyme with the Kinetics of Native Enzymes. Science 2016, 354, 102–106. 10.1126/science.aah4427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Key H. M.; Dydio P.; Clark D. S.; Hartwig J. F. Abiological Catalysis by Artificial Haem Proteins Containing Noble Metals in Place of Iron. Nature 2016, 534, 534–537. 10.1038/nature17968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gu Y.; Natoli S. N.; Liu Z.; Clark D. S.; Hartwig J. F. Site-Selective Functionalization of (Sp3)C–H Bonds Catalyzed by Artificial Metalloenzymes Containing an Iridium-Porphyrin Cofactor. Angew. Chem., Int. Ed. 2019, 58, 13954–13960. 10.1002/anie.201907460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Z.; Huang J.; Gu Y.; Clark D. S.; Mukhopadhyay A.; Keasling J. D.; Hartwig J. F. Assembly and Evolution of Artificial Metalloenzymes within E. Coli Nissle 1917 for Enantioselective and Site-Selective Functionalization of C–H and C=C Bonds. J. Am. Chem. Soc. 2022, 144, 883–890. 10.1021/jacs.1c10975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sreenilayam G.; Moore E. J.; Steck V.; Fasan R. Metal Substitution Modulates the Reactivity and Extends the Reaction Scope of Myoglobin Carbene Transfer Catalysts. Adv. Synth. Catal. 2017, 359, 2076–2089. 10.1002/adsc.201700202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vargas D. A.; Tinoco A.; Tyagi V.; Fasan R. Myoglobin-Catalyzed C–H Functionalization of Unprotected Indoles. Angew. Chem., Int. Ed. 2018, 57, 9911–9915. 10.1002/anie.201804779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hyster T. K.; Knörr L.; Ward T. R.; Rovis T. Biotinylated Rh(III) Complexes in Engineered Streptavidin for Accelerated Asymmetric C–H Activation. Science 2012, 338, 500–503. 10.1126/science.1226132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hassan I. S.; Ta A. N.; Danneman M. W.; Semakul N.; Burns M.; Basch C. H.; Dippon V. N.; McNaughton B. R.; Rovis T. Asymmetric δ-Lactam Synthesis with a Monomeric Streptavidin Artificial Metalloenzyme. J. Am. Chem. Soc. 2019, 141, 4815–4819. 10.1021/jacs.9b01596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Facchetti G.; Rimoldi I. 8-Amino-5,6,7,8-Tetrahydroquinoline in Iridium(III) Biotinylated Cp* Complex as Artificial Imine Reductase. New J. Chem. 2018, 42, 18773–18776. 10.1039/C8NJ04558E. [DOI] [Google Scholar]
- Reetz M. T. Directed Evolution of Artificial Metalloenzymes: A Universal Means to Tune the Selectivity of Transition Metal Catalysts?. Acc. Chem. Res. 2019, 52, 336–344. 10.1021/acs.accounts.8b00582. [DOI] [PubMed] [Google Scholar]
- Lewis J. C. Beyond the Second Coordination Sphere: Engineering Dirhodium Artificial Metalloenzymes To Enable Protein Control of Transition Metal Catalysis. Acc. Chem. Res. 2019, 52, 576–584. 10.1021/acs.accounts.8b00625. [DOI] [PubMed] [Google Scholar]
- Lin C.-C.; Lin C.-W.; Chan A. S. C. Catalytic Hydrogenation of Itaconic Acid in a Biotinylated Pyrphos–Rhodium(I) System in a Protein Cavity. Tetrahedron: Asymmetry 1999, 10, 1887–1893. 10.1016/S0957-4166(99)00193-7. [DOI] [Google Scholar]
- Liang A. D.; Serrano-Plana J.; Peterson R. L.; Ward T. R. Artificial Metalloenzymes Based on the Biotin–Streptavidin Technology: Enzymatic Cascades and Directed Evolution. Acc. Chem. Res. 2019, 52, 585–595. 10.1021/acs.accounts.8b00618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roy A.; Vaughn M. D.; Tomlin J.; Booher G. J.; Kodis G.; Simmons C. R.; Allen J. P.; Ghirlanda G. Enhanced Photocatalytic Hydrogen Production by Hybrid Streptavidin-Diiron Catalysts. Chem.–Eur. J. 2020, 26, 6240–6246. 10.1002/chem.202000204. [DOI] [PubMed] [Google Scholar]
- Santi N.; Morrill L. C.; Luk L. Y. P. Streptavidin-Hosted Organocatalytic Aldol Addition. Molecules 2020, 25, 2457. 10.3390/molecules25102457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vornholt T.; Christoffel F.; Pellizzoni M. M.; Panke S.; Ward T. R.; Jeschek M. Systematic Engineering of Artificial Metalloenzymes for New-to-Nature Reactions. Sci. Adv. 2021, 7, eabe4208 10.1126/sciadv.abe4208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qin Y.; Cui C.; Jäkle F. Tris(1-Pyrazolyl)Borate (Scorpionate) Functionalized Polymers as Scaffolds for Metallopolymers. Macromolecules 2008, 41, 2972–2974. 10.1021/ma800310v. [DOI] [Google Scholar]
- Zagermann J.; Kuchta M. C.; Merz K.; Metzler-Nolte N. Para-Bromophenyl[Tris(Pyrazolyl)]Borate Complexes of Group 1 Metals, Thallium and Magnesium: Synthesis and Characterization of Transfer Agents for “Third-Generation” Tp Ligands. Eur. J. Inorg. Chem. 2009, 2009, 5407–5412. 10.1002/ejic.200900707. [DOI] [Google Scholar]
- Nakamizu A.; Kasai T.; Nakazawa J.; Hikichi S. Immobilization of a Boron Center-Functionalized Scorpionate Ligand on Mesoporous Silica Supports for Heterogeneous Tp-Based Catalysts. ACS Omega 2017, 2, 1025–1030. 10.1021/acsomega.7b00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desrochers P. J.; Besel B. M.; Corken A. L.; Evanov J. R.; Hamilton A. L.; Nutt D. L.; Tarkka R. M. Immobilized Boron-Centered Heteroscorpionates: Heterocycle Metathesis and Coordination Chemistry. Inorg. Chem. 2011, 50, 1931–1941. 10.1021/ic102392x. [DOI] [PubMed] [Google Scholar]
- Soares da Costa T. P.; Tieu W.; Yap M. Y.; Zvarec O.; Bell J. M.; Turnidge J. D.; Wallace J. C.; Booker G. W.; Wilce M. C. J.; Abell A. D.; Polyak S. W. Biotin Analogues with Antibacterial Activity Are Potent Inhibitors of Biotin Protein Ligase. ACS Med. Chem. Lett. 2012, 3, 509–514. 10.1021/ml300106p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skander M.; Humbert N.; Collot J.; Gradinaru J.; Klein G.; Loosli A.; Sauser J.; Zocchi A.; Gilardoni F.; Ward T. R. Artificial Metalloenzymes: (Strept)Avidin as Host for Enantioselective Hydrogenation by Achiral Biotinylated Rhodium–Diphosphine Complexes. J. Am. Chem. Soc. 2004, 126, 14411–14418. 10.1021/ja0476718. [DOI] [PubMed] [Google Scholar]
- Wang Z.-X. An Exact Mathematical Expression for Describing Competitive Binding of Two Different Ligands to a Protein Molecule. FEBS Lett. 1995, 360, 111–114. 10.1016/0014-5793(95)00062-E. [DOI] [PubMed] [Google Scholar]
- Martín C.; Belderraín T. R.; Pérez P. J. Rediscovering Copper-Based Catalysts for Intramolecular Carbon–Hydrogen Bond Functionalization by Carbene Insertion. ACS Catal. 2009, 7, 4777. 10.1039/b911589g. [DOI] [PubMed] [Google Scholar]
- Caruano J.; Muccioli G. G.; Robiette R. Biologically Active γ-Lactams: Synthesis and Natural Sources. Org. Biomol. Chem. 2016, 14, 10134–10156. 10.1039/C6OB01349J. [DOI] [PubMed] [Google Scholar]
- Singh G. S. Beta-Lactams in the New Millennium. Part-I: Monobactams and Carbapenems. Mini-Rev. Med. Chem. 2004, 4, 69–92. 10.2174/1389557043487501. [DOI] [PubMed] [Google Scholar]
- Singh G. S. Beta-Lactams in the New Millennium. Part-II: Cephems, Oxacephems, Penams and Sulbactam. Mini-Rev. Med. Chem. 2004, 4, 93–109. 10.2174/1389557043487547. [DOI] [PubMed] [Google Scholar]
- Ren X.; Chandgude A. L.; Fasan R. Highly Stereoselective Synthesis of Fused Cyclopropane-γ-Lactams via Biocatalytic Iron-Catalyzed Intramolecular Cyclopropanation. ACS Catal. 2020, 10, 2308–2313. 10.1021/acscatal.9b05383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mallin H.; Hestericová M.; Reuter R.; Ward T. R. Library Design and Screening Protocol for Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology. Nat. Protoc. 2016, 11, 835–852. 10.1038/nprot.2016.019. [DOI] [PubMed] [Google Scholar]
- Li H.; Ma X.; Lei M. Substituent Effects and Chemoselectivity of the Intramolecular Buchner Reaction of Diazoacetamide Derivatives Catalyzed by the Di-Rh(II)-Complex. Dalton Trans. 2016, 45, 8506–8512. 10.1039/C6DT00268D. [DOI] [PubMed] [Google Scholar]
- Wee A. G. H.; Duncan S. C.; Fan G. Intramolecular Asymmetric C–H Insertion of N-Arylalkyl, N-Bis(Trimethylsilyl)Methyldiazoamides Mediated by Chiral Rhodium(II) Catalysts. Synthesis of (R)-β-Benzyl-γ-Aminobutyric Acid. Tetrahedron: Asymmetry 2006, 17, 297–307. 10.1016/j.tetasy.2005.12.020. [DOI] [Google Scholar]
- St. John P. C.; Kim Y.; Kim S.; Paton R. S.; Paton R. S. Prediction of Organic Homolytic Bond Dissociation Enthalpies at near Chemical Accuracy with Sub-Second Computational Cost. Nat. Commun. 2020, 11, 2328. 10.1038/s41467-020-16201-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pedroni J.; Boghi M.; Saget T.; Cramer N. Access to β-Lactams by Enantioselective Palladium(0)-Catalyzed C(Sp3)-H Alkylation. Angew. Chem., Int. Ed. 2014, 53, 9064–9067. 10.1002/anie.201405508. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







